Ovid Therapeutics Inc. (NASDAQ:OVID) Sees Significant Growth in Short Interest
Ovid Therapeutics Inc. (NASDAQ:OVID – Get Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 947,800 shares, a growth of 28.0% from the November 30th total of 740,300 shares. Based on an average daily trading volume, of 212,600 shares, the days-to-cover ratio is currently 4.5 days. Currently, 1.7% of the company’s shares are short sold.
Source link
